|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
58
|
|
pubmed:dateCreated |
2004-7-8
|
|
pubmed:abstractText |
There have been a few clinical reports about beta-catenin nuclear expression for hepatocellular carcinoma patients. However, the clinical significance of the nuclear expression has not been fully elucidated and remains to be controversial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0172-6390
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
921-4
|
|
pubmed:dateRevised |
2005-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15239213-Adult,
pubmed-meshheading:15239213-Aged,
pubmed-meshheading:15239213-Antibodies, Monoclonal,
pubmed-meshheading:15239213-Blotting, Western,
pubmed-meshheading:15239213-Carcinoma, Hepatocellular,
pubmed-meshheading:15239213-Cell Nucleus,
pubmed-meshheading:15239213-Cytoskeletal Proteins,
pubmed-meshheading:15239213-Female,
pubmed-meshheading:15239213-Humans,
pubmed-meshheading:15239213-Immunohistochemistry,
pubmed-meshheading:15239213-Liver Neoplasms,
pubmed-meshheading:15239213-Male,
pubmed-meshheading:15239213-Middle Aged,
pubmed-meshheading:15239213-Multivariate Analysis,
pubmed-meshheading:15239213-Neoplasm Staging,
pubmed-meshheading:15239213-Prognosis,
pubmed-meshheading:15239213-Staining and Labeling,
pubmed-meshheading:15239213-Survival Analysis,
pubmed-meshheading:15239213-Trans-Activators,
pubmed-meshheading:15239213-beta Catenin
|
|
pubmed:articleTitle |
Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma.
|
|
pubmed:affiliation |
Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
|
|
pubmed:publicationType |
Journal Article
|
